Inhibition of apoptosis in a human pre-B-cell line by CD23 is mediated via a novel receptor

Blood

Volumn 90, Issue 1, 1997, Pages 234-243

  White, Lindsey J ^b   Ozanne, Bradford W ^b   Graber, Pierre ^b   Aubry, Jean Pierre ^b   Bonnefoy, Jean Yves ^b   Cushley, William ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD23 ANTIGEN; CELL RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKINE; DIFFERENTIATION ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN E RECEPTOR; MESSENGER RNA; PROTEIN BCL 2;

ACUTE LYMPHOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0030985193     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.234     Document Type: Article

References (39)

1. Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A: Expression, structure and function of the CD23 antigen. Adv Immunol 49:149, 1991
2. Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M: The low affinity receptor for IgE. Immunol Rev 125:77, 1992
3. εRII/CD23). Crit Rev Immunol 11:65, 1991
4. Bonnefoy J-Y, Aubry J-P, Gauchat J-F, Graber P, Life P, Flores-Romo L, Mazzei G: Receptors for IgE. Curr Opin Immunol 5:944, 1993
5. εRII/CD23) and related C-type lectins. Proc Natl Acad Sci USA 89:753, 1992
6. εRII and its soluble fragments can form oligomers on the cell surface and in solution. Immunology 84:202, 1995
7. Bonnefoy J-Y, Aubry J-P, Peronne C, Wijdenes J, Banchereau J: Production and characterisation of a mAb specific for the human low affinity receptor for IgE: CD23 is a low affinity receptor for IgE. J Immunol 138:2970, 1987
8. εR) on lymphocytes. J Immunol 138:2576, 1987
9. Flores-Romo L, Shields J, Humbert Y, Graber P, Aubry J-P, Gauchat J-F, Ayala G, Allet B, Chavez M, Bazin H, Capron M, Bonnefoy J-Y: Inhibition of an in vivo antigen specific IgE response by antibodies to CD23. Science 261:1038, 1993
10. Aubry JP, Pochon S, Graber P, Jansen KU, Bonnefoy JY: CD21 is a ligand for CD23 and regulated IgE production. Nature 358:505, 1992
11. Björck P, Elenström-Magnusson C, Rosén A, Severinson E, Paulie S: CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur J Immunol 23:1771, 1993
12. Flores-Romo L, Johnson GD, Ghaderi AA, Stanworth DR, Veronesi A, Gordon J: Functional implication for the topographical relationship between MHC class II and the low affinity IgE receptor: Occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses. Eur J Immunol 20:2465, 1990
13. ε receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J Exp Med 164:1455, 1986
14. Yokota A, Kikutani H, Tanaka T, Sato R, Barsumain EL, Suemura M, Kishimoto T: Two species of human Fc epsilon receptor II (FcεRII / CD23): Tissue-specific and IL-4 specific regulation of gene expression. Cell 55:611, 1988
15. Law CL, Armitage RJ, Villablanca JG, LeBein TW: Expression of interleukin-4 receptors on early human B-lineage cells. Blood 78:703, 1991
16. Letellier M, Sarfati M, Delespesse G: Mechanisms of formation of IgE-binding factors (soluble CD23). I. Fc epsilon RII bearing B cells generate IgE binding factors of different molecular weights. Mol Immunol 26:1105, 1989
17. Gordon J, Flores-Romo L, Cairns JA, Millsum MJ, Lane PJ, Johnson GD, MacLennan ICM: CD23: A multi-functional receptor/ lymphokine? Immunol Today 10:153, 1989
18. Swendeman S, Thorely-Lawson DA: The activation antigen Blast 2, when shed, is an autocrine growth factor for normal and transformed B cells. EMBO J 6:1637, 1987
19. Mossalayi D, Lecron J-C, Dalloul AH, Sarfati M, Bertho J-M, Hofstetter, H, Delespesse G, Debre P: Soluble CD23 (FcεRII) and interleukin 1 synergistically induce early human thymocyte maturation. J Exp Med 171:959, 1990
20. Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, Maclennan ICM: Recombinant 25-kDa CD23 and interleukin-1α promote the survival of germinal centre B cells: Evidence for birfurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 21:1107, 1991
21. Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM: Germinal centre cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905, 1991
22. Mossalayi MD, Arock M, Delespesse G, Hofstetter H, Bettler B, Dalloul AH, Killcher E, Quaaz F, Debré P, Sarfati M: Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. EMBO J 11:4323, 1992
23. Hellen EA, Rowlands DC, Hansel TT, Kitas GD, Crocker J: Immunochemical demonstration of CD23 expression on lymphocytes in rheumatoid arthritis. J Clin Pathol 44:293, 1991
24. Yanagihara Y, Sarfati M, Marsh D, Nutman T, Delespesse G: Serum levels of IgE binding factor (CD23) in diseases associated with elevated IgE. Clin Exp Allergy 20:395, 1990
25. Sarfati M, Bron D, Lagneaux L, Fonteyn C, Frost H, Delespesse G: Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 71:94, 1988
26. Lecoanet-Henchoz S, Gauchat J-F, Aubry J-P, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C, Bonnefoy J-Y: CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 2:1, 1995
27. Tanner J, Weis J, Fearton DT, Whang Y, Keiff E: Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50:203, 1987
28. Weis JJ, Tedder TF, Fearon DT: Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci USA 81:881, 1984
29. Pochon S, Graber P, Yeager M, Jansen K, Bernard AR, Aubry J-P, Bonnefoy J-Y: Demonstration of a second ligand for the low affinity receptor for IgE (CD23) using recombinant CD23 reconstituted into fluorescent liposomes. J Exp Med 176:389, 1992
30. Aubry J-P, Pochon S, Gauchat J-F, Nueda-Marin A, Holers VM, Graber P, Siegfried C, Bonnefoy J-F: CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J Immunol 152:5806, 1994
31. Smith RG: Paraosteal Lymphoblastic Lymphoma: A human counterpart of Abelson Virus-induced lymphosarcoma of mice. Cancer 54:471, 1984
32. Tsai L-H, Nanu L, Smith RG, Ozanne B: Overexpression of c-fos in a human pre-B cell acute lymphocytic leukemia derived cell line, SMS-SB. Oncogene 6:81, 1991
33. Jansen KU, Shields J, Gordon J, Cairns P, Graber P, Bonnefoy J-Y: Expression of human recombinant CD23 in insect cells. J Recept Res 11:507, 1991
34. Rose K, Turcatti G, Graber P, Pochon S, Regamey PO, Jansen KU, Magnenat E, Aubonney N, Bonnefoy J-Y: Partial characterisation of natural and recombinant soluble CD23. Biochem J 286:819, 1992
35. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH: Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133:275, 1992
36. Tsai L-H, White LJ, Raines E, Ross R, Smith RG, Cushley W, Ozanne BW: Expression of platelet-derived growth factor and its receptors by two pre-B acute lymphocytic leukemia cell lines. Blood 83:51, 1994
37. Bonnefoy J-Y, Henchoz S, Hardie D, Holder MJ, Gordon J: A subset of anti-CD21 antibodies promote the rescue of germinal centre B cells from apoptosis. Eur J Immunol 23:969, 1993
38. Barnett D, Reilly JT: Lack of correlation between cell surface activation, antigen expression and clinical stage in B-CLL. Br J Haematol 73:572, 1989
39. Fourcade C, Arock M, Ktorza S, Quaaz F, Merle-Béral H, Mentz F, Kilchherr E, Debré P, Mossalayi MD: Expression of CD23 by human bone marrow stromal cells. Eur Cytokine Netw 3:539, 1992